Achieve Life Sciences, Inc.
(NASDAQ : ACHV)

( )
ACHV PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
Loading ACHV News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
0.32%73.350.9%$628.11m
CELGCelgene Corporation
-0.08%131.261.1%$437.57m
AMGNAmgen Inc.
0.79%171.391.1%$428.25m
VRTXVertex Pharmaceuticals Incorporated
-0.88%151.371.9%$388.67m
BIIBBiogen Inc.
2.14%294.081.2%$369.29m
REGNRegeneron Pharmaceuticals, Inc.
-0.85%468.542.7%$323.23m
ALXNAlexion Pharmaceuticals, Inc.
0.99%136.551.9%$224.00m
ILMNIllumina, Inc.
0.12%194.153.5%$222.63m
SRPTSarepta Therapeutics, Inc.
1.96%37.4319.8%$145.52m
INCYIncyte Corporation
-1.61%124.342.6%$135.50m
CLVSClovis Oncology, Inc.
-0.15%71.7718.0%$123.60m
KITEKite Pharma, Inc.
1.02%128.0916.1%$116.66m
TSROTESARO, Inc.
-0.89%112.9914.7%$114.54m
BMRNBioMarin Pharmaceutical Inc.
-0.01%83.074.4%$113.75m
AAgilent Technologies, Inc.
4.67%62.151.5%$112.87m

Company Profile

Achieve Life Sciences, Inc. is a pharmaceutical company which develops treatment option to help people battling nicotine addiction. It offers Cytisine, which is a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. Its activities also include research and development, raising capital, building management team, and seeking additional patent approvals. The company was founded on May 12, 2015 and is headquartered in Bothell, WA.